Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-014414
Filing Date
2012-03-05
Accepted
2012-03-05 18:44:18
Documents
1
Period of Report
2012-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd336972.html 4  
1 FORM 4 rrd336972.xml 4 4090
  Complete submission text file 0001181431-12-014414.txt   5462
Mailing Address C/O SPIROS DEVELOPMENT CORP II INC 7475 LUSK BLVD SAN DIEGO CA 92121
Business Address
MAST ERLE T (Reporting) CIK: 0001051411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 12668170

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations